Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial

[1] Maddahi J(2011)Phase I, first-in-human study of BMS-747158, a novel J Nucl Med 52 1490-1498

[2] Czernin J(2013)F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest J Am Coll Cardiol 61 469-477

[3] Lazewatsky J(2011)Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F 18 positron emission tomography Semin Nucl Med 41 305-313

[4] Berman DS(2009)The next generation of cardiac positron emission tomography imaging agents: Discovery of flurpiridaz F-18 for detection of coronary disease Circulation 119 2333-2342

[5] Maddahi J(2011)Evaluation of the novel myocardial perfusion positron-emission tomography tracer J Nucl Med 52 617-624

[6] Tamarappoo BK(2017)F-BMS-747158-02: Comparison to Eur J Nucl Med Mol Imaging 44 1538-1546

[7] Yu M(2014)N-ammonia and validation with microspheres in a pig model J Nucl Med 55 1438-1444

[8] Nekolla SG(1998)Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model J Am Coll Cardiol 31 534-540

[9] Schwaiger M(2009)Single-scan rest/stress imaging: Validation in a porcine model with J Am Coll Cardiol Imaging 2 751-758

[10] Robinson SP(2012)F-flurpiridaz J Nucl Med 53 1230-1234

[1] Maddahi J(2011)Phase I, first-in-human study of BMS-747158, a novel J Nucl Med 52 1490-1498

[2] Czernin J(2013)F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest J Am Coll Cardiol 61 469-477

[3] Lazewatsky J(2011)Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F 18 positron emission tomography Semin Nucl Med 41 305-313

[4] Berman DS(2009)The next generation of cardiac positron emission tomography imaging agents: Discovery of flurpiridaz F-18 for detection of coronary disease Circulation 119 2333-2342

[5] Maddahi J(2011)Evaluation of the novel myocardial perfusion positron-emission tomography tracer J Nucl Med 52 617-624

[6] Tamarappoo BK(2017)F-BMS-747158-02: Comparison to Eur J Nucl Med Mol Imaging 44 1538-1546

[7] Yu M(2014)N-ammonia and validation with microspheres in a pig model J Nucl Med 55 1438-1444

[8] Nekolla SG(1998)Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model J Am Coll Cardiol 31 534-540

[9] Schwaiger M(2009)Single-scan rest/stress imaging: Validation in a porcine model with J Am Coll Cardiol Imaging 2 751-758

[10] Robinson SP(2012)F-flurpiridaz J Nucl Med 53 1230-1234